Testing the feasibility and safety of feeding preterm infants fresh mother's own milk in the NICU: A pilot study

Huiqing Sun, Shuping Han, Rui Cheng, Mingyan Hei, Foteini Kakulas, Shoo K Lee, Huiqing Sun, Shuping Han, Rui Cheng, Mingyan Hei, Foteini Kakulas, Shoo K Lee

Abstract

Necrotizing enterocolitis (NEC) is the leading cause of death among infants born at <30 weeks' gestation, but donor human milk can reduce the incidence of NEC. Unfortunately, freezing or pasteurizing human milk deactivates beneficial bioactive components. We evaluated the feasibility, safety, and impact of feeding very preterm infants fresh (unprocessed) mother's own milk within 4 hours of expression. In our multicentre prospective cohort analytic study, we fed 109 control and 98 intervention infants previously frozen donor or mother's own milk; only the intervention group was fed fresh mother's own milk once daily from enrollment until 32 weeks' corrected age. Control group mothers could not commit to provide fresh milk daily and were less likely receive antenatal corticosteroids than mothers in the intervention group. In the intervention group, 87.5% (98/112) of mothers were able to provide at least one feed of fresh milk a day. No critical incidents or non-compliance with the protocol were reported. The duration of mechanical ventilation and total parenteral nutrition use were shorter in the intervention group than controls (P < 0.01) but the length of hospital stay was similar (P = 0.57). Although the study might be underpowered, the intervention group had lower unadjusted rates of the composite outcome NEC ≥ stage 2 or mortality (8% vs 20%, P = 0.04), sepsis (22% vs 38%, P = 0.02), retinopathy of prematurity (17% vs 39%, P < 0.01) and bronchopulmonary dysplasia (32% vs 47%, P < 0.01) than the control. These results indicated that feeding fresh mother's own milk once daily was safe, feasible, and may reduce morbidity.

Trial registration: ClinicalTrials.gov NCT03258957.

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Consort Diagram Flow chart of included infants.

References

    1. Berman L, Moss RL. Necrotizing enterocolitis: an update. Semin Fetal Neonatal Med. 2011;16:145–150. doi: 10.1016/j.siny.2011.02.002.
    1. Dominguez KM, Moss RL. Necrotizing enterocolitis. Clin Perinatol. 2012;39:387–401. doi: 10.1016/j.clp.2012.04.011.
    1. Alshaikh B, Kostecky L, Blachly N, Yee W. Effect of a Quality Improvement Project to Use Exclusive Mother’s Own Milk on Rate of Necrotizing Enterocolitis in Preterm Infants. Breastfeed Med. 2015;10:355–361. doi: 10.1089/bfm.2015.0042.
    1. Quigley, M. & McGuire, W. Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev, Cd002971, (2014).
    1. Li C, Solomons NW, Scott ME, Koski KG. Subclinical mastitis (SCM) and proinflammatory cytokines are associated with mineral and trace element concentrations in human breast milk. J Trace Elem Med Biol. 2018;46:55–61. doi: 10.1016/j.jtemb.2017.11.010.
    1. Khodabakhshi A, Mehrad-Majd H, Vahid F, Safarian M. Association of maternal breast milk and serum levels of macronutrients, hormones, and maternal body composition with infant’s body weight. Eur J Clin Nutr. 2018;72:394–400. doi: 10.1038/s41430-017-0022-9.
    1. Xiao L, et al. Human Milk Oligosaccharide 2’-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model. Front Immunol. 2018;9:452. doi: 10.3389/fimmu.2018.00452.
    1. Hassiotou F, Geddes DT, Hartmann PE. Cells in human milk: state of the science. J Hum Lact. 2013;29:171–182. doi: 10.1177/0890334413477242.
    1. Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am. 2013;60:49–74. doi: 10.1016/j.pcl.2012.10.002.
    1. Underwood MA. Human milk for the premature infant. Pediatr Clin North Am. 2013;60:189–207. doi: 10.1016/j.pcl.2012.09.008.
    1. Hassiotou F, Geddes DT. Immune cell-mediated protection of the mammary gland and the infant during breastfeeding. Adv Nutr. 2015;6:267–275. doi: 10.3945/an.114.007377.
    1. Hassiotou F, Hartmann PE. At the dawn of a new discovery: the potential of breast milk stem cells. Adv Nutr. 2014;5:770–778. doi: 10.3945/an.114.006924.
    1. Kakulas F. Breast milk: a source of stem cells and protective cells for the infant. Infant. 2015;11:187–191.
    1. Hassiotou F, et al. Breastmilk is a novel source of stem cells with multilineage differentiation potential. Stem Cells. 2012;30:2164–2174. doi: 10.1002/stem.1188.
    1. Hassiotou FHB, et al. Breastmilk stem cell transfer from mother to neonatal organs (216.4) The FASEB Journal. 2014;28:216.214.
    1. Hassiotou FMA, Geddes D, Hartmann P, Wilkie TBreastmilk. Imparts the Mother’s Stem Cells to the Infant. The FASEB Journal. 2015;29:876.878.
    1. Dicky O, et al. Policy of feeding very preterm infants with their mother’s own fresh expressed milk was associated with a reduced risk of bronchopulmonary dysplasia. Acta paediatr. 2017;106:755–762. doi: 10.1111/apa.13757.
    1. Garcia-Lara NR, et al. Effect of freezing time on macronutrients and energy content of breastmilk. Breastfeed Med. 2012;7:295–301. doi: 10.1089/bfm.2011.0079.
    1. Lev HM, et al. Major losses of fat, carbohydrates and energy content of preterm human milk frozen at −80 degrees C. J Perinatol. 2014;34:396–398. doi: 10.1038/jp.2014.8.
    1. Akinbi H, et al. Alterations in the host defense properties of human milk following prolonged storage or pasteurization. J Pediatr Gastroenterol Nutr. 2010;51:347–352.
    1. Chang JC, et al. Influence of prolonged storage process, pasteurization, and heat treatment on biologically-active human milk proteins. Pediatr Neonatol. 2013;54:360–366. doi: 10.1016/j.pedneo.2013.03.018.
    1. Sari FN, et al. Antioxidant capacity of fresh and stored breast milk: is −80 degrees C optimal temperature for freeze storage? J Matern Fetal Neonatal Med. 2012;25:777–782. doi: 10.3109/14767058.2011.592230.
    1. Silvestre D, et al. Frozen breast milk at −20 degrees C and −80 degrees C: a longitudinal study of glutathione peroxidase activity and malondialdehyde concentration. J Hum Lact. 2010;26:35–41. doi: 10.1177/0890334409342987.
    1. Hassiotou F, Savigni D, Hartmann P, Geddes D. Optimization of Cell Isolation from Human Milk. The FASEB Journal. 2015;29:582.587.
    1. Anne-Aurelie L, Souad B, Leila K. Clinical Findings and Autopsy of a Preterm Infant with Breast Milk-Acquired Cytomegalovirus Infection. AJP Rep. 2016;6:e198–202. doi: 10.1055/s-0035-1566249.
    1. Fernandez L, et al. The human milk microbiota: origin and potential roles in health and disease. Pharmacol Res. 2013;69:1–10. doi: 10.1016/j.phrs.2012.09.001.
    1. de Jong EP, Vossen AC, Walther FJ, Lopriore E. How to use… neonatal TORCH testing. Arch Dis Child Educ Pract Ed. 2013;98:93–98. doi: 10.1136/archdischild-2012-303327.
    1. Nahmias AJ, Walls KW, Stewart JA, Herrmann KL, Flynt WJ., Jr. The ToRCH complex-perinatal infections associated with toxoplasma and rubella, cytomegol-and herpes simplex viruses. Pediatr Res. 1971;5:405–406. doi: 10.1203/00006450-197108000-00144.
    1. Fenton TR. A new growth chart for preterm babies: Babson and Benda’s chart updated with recent data and a new format. BMC Pediatr. 2003;3:13. doi: 10.1186/1471-2431-3-13.
    1. Bell MJ, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187:1–7.
    1. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol123, 991–999 (2005).
    1. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–1729. doi: 10.1164/ajrccm.163.7.2011060.
    1. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92:529–534. doi: 10.1016/S0022-3476(78)80282-0.
    1. Bransburg-Zabary S, Virozub A, Mimouni FB. Human Milk Warming Temperatures Using a Simulation of Currently Available Storage and Warming Methods. PLoS One. 2015;10:e0128806. doi: 10.1371/journal.pone.0128806.
    1. Arena Ansotegui J. Breastfeeding in the “global strategy for infant and young child feeding”. An Pediatr (Barc) 2003;58:208–210.
    1. Boyd AE, Spatz DL. Breastfeeding and human lactation: education and curricular issues for pediatric nurse practitioners. J Pediatr Health Care. 2013;27:83–90. doi: 10.1016/j.pedhc.2011.03.005.
    1. Handa D, et al. Do thawing and warming affect the integrity of human milk? J Perinatol. 2014;34:863–866. doi: 10.1038/jp.2014.113.
    1. Garcia-Lara NR, et al. Effect of Holder pasteurization and frozen storage on macronutrients and energy content of breast milk. J Pediatr Gastroenterol Nutr. 2013;57:377–382. doi: 10.1097/MPG.0b013e31829d4f82.
    1. Josephson CD, et al. Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: a prospective cohort study. JAMA Pediatr. 2014;168:1054–1062. doi: 10.1001/jamapediatrics.2014.1360.
    1. Cossey V, et al. Pasteurization of mother’s own milk for preterm infants does not reduce the incidence of late-onset sepsis. Neonatology. 2013;103:170–176. doi: 10.1159/000345419.
    1. Nangia, S. et al. Early Total Enteral Feeding in Stable Very Low Birth Weight Infants: A Before and After Study. J Trop Pediatr. (2018).
    1. Sandal G, et al. Evaluation of treatment with hydrocortisone on oxidant/antioxidant system in preterm infants with BPD. Eur Rev Med Pharmacol Sci. 2013;17:2594–2597.
    1. Mehta R, Petrova A. Is variation in total antioxidant capacity of human milk associated with levels of bio-active proteins? J Perinatol. 2014;34:220–222. doi: 10.1038/jp.2013.151.
    1. Silvestre D, et al. Antioxidant capacity of human milk: effect of thermal conditions for the pasteurization. Acta paediatr. 2008;97:1070–1074. doi: 10.1111/j.1651-2227.2008.00870.x.
    1. Tsopmo A, et al. Tryptophan released from mother’s milk has antioxidant properties. Pediatr Res. 2009;66:614–618. doi: 10.1203/PDR.0b013e3181be9e7e.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi